15 Sep 2010 12:04
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
BIOFUTURES INTERNATIONAL PLC |
2 Reason for the notification (please tick the appropriate box or boxes): | ||
An acquisition or disposal of voting rights | ü | |
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| |
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| |
An event changing the breakdown of voting rights |
| |
Other (please specify): |
|
|
3. Full name of person(s) subject to the notification obligation:
| Q CAPITAL LLP |
4. Full name of shareholder(s) (if different from 3.):
|
|
5. Date of the transaction and date on which the threshold is crossed or reached:
|
9 SEPTEMBER 2010 |
6. Date on which issuer notified:
|
15 SEPTEMBER 2010 |
7. Threshold(s) that is/are crossed or reached:
|
5% |
8. Notified details: | |||||||
A: Voting rights attached to shares
| |||||||
Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | |||||
Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights | |||
Direct | Direct | Indirect | Direct | Indirect | |||
ORDINARY GB00B12B4T47
| 8,750,000 | 8,750,000 | 7,100,000 | 7,100,000 | - | 4.70% | - |
B: Qualifying Financial Instruments | ||||
Resulting situation after the triggering transaction
| ||||
Type of financial instrument | Expiration date | Exercise/ Conversion Period | Number of voting rights that may be acquired if the instrument is exercised/ converted.
| % of voting rights |
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||
Resulting situation after the triggering transaction
| ||||||
Type of financial instrument | Exercise price | Expiration date | Exercise/ Conversion period | Number of voting rights instrument refers to | % of voting rights
| |
|
|
|
|
|
|
|
|
|
Total (A+B+C)
| |
Number of voting rights | Percentage of voting rights |
7,100,000 | 4.70% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
|
Proxy Voting:
| |
10. Name of the proxy holder:
|
|
11. Number of voting rights proxy holder will cease to hold:
|
|
12. Date on which proxy holder will cease to hold voting rights:
|
|
13. Additional information:
|
|
14. Contact name:
| NEIL GRAHAM |
15. Contact telephone number:
| +44(0) 1733 568491 |
For further information contact: |
JOE WONG, CEO, BIOFUTURES INTERNATIONAL PLC - +6012 31 0626
DEREK CROWHURST, RELIGARE CAPITAL MARKETS (NOMAD) - 0207 444 0800
DANIEL BRIGGS, RELIGARE CAPITAL MARKETS (BROKER) - 0207 444 0500 |